These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 8233270

  • 1. Macrophage colony-stimulating factor as a tumor marker for epithelial ovarian cancer.
    Suzuki M, Ohwada M, Aida I, Tamada T, Hanamura T, Nagatomo M.
    Obstet Gynecol; 1993 Dec; 82(6):946-50. PubMed ID: 8233270
    [Abstract] [Full Text] [Related]

  • 2. [Macrophage-colony stimulating factor and ovarian cancer].
    Menditto A, Piscittelli V, Cassese F, Balbi GC, Balbi C, Cardone A.
    Minerva Ginecol; 1999 Dec; 51(7-8):261-4. PubMed ID: 10536419
    [Abstract] [Full Text] [Related]

  • 3. [The plasma levels and diagnostic utility of granulocyte colony stimulating factor (G-CSF) and macrophage - colony stimulating factor (M-CSF) in ovarian cancer patients].
    ławicki S, Czygier M, Gacuta-Szumarska E, Knapp P, Szmitkowski M.
    Pol Merkur Lekarski; 2006 Nov; 21(125):465-8. PubMed ID: 17345841
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary.
    Suzuki M, Tamura N, Kobayashi H, Ohwada M, Terao T, Sato I.
    Gynecol Oncol; 2000 Jun; 77(3):405-9. PubMed ID: 10831350
    [Abstract] [Full Text] [Related]

  • 5. Macrophage colony-stimulating factor as a marker for malignant germ cell tumors of the ovary.
    Suzuki M, Kobayashi H, Ohwada M, Terao T, Sato I.
    Gynecol Oncol; 1998 Jan; 68(1):35-7. PubMed ID: 9454657
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK, Kacinski BM, Ivins CM, Carcangiu ML.
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [Abstract] [Full Text] [Related]

  • 7. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
    Baron AT, Lafky JM, Boardman CH, Balasubramaniam S, Suman VJ, Podratz KC, Maihle NJ.
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
    [Abstract] [Full Text] [Related]

  • 8. [Study on serum vascular endothelial growth factor level in ovarian malignant tumors].
    Li L, Wang LM, Zhang W, Zhang JQ, Song HL, Yao DS, Tang Y, Chen XQ, Yang ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):72-6. PubMed ID: 12783691
    [Abstract] [Full Text] [Related]

  • 9. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B, Groblewska M, Wereszczyńska-Siemiatkowska U, Okulczyk B, Kedra B, Łaszewicz W, Dabrowski A, Szmitkowski M.
    Clin Chim Acta; 2007 May 01; 380(1-2):208-12. PubMed ID: 17368603
    [Abstract] [Full Text] [Related]

  • 10. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.
    Smith HO, Anderson PS, Kuo DY, Goldberg GL, DeVictoria CL, Boocock CA, Jones JG, Runowicz CD, Stanley ER, Pollard JW.
    Clin Cancer Res; 1995 Mar 01; 1(3):313-25. PubMed ID: 9815987
    [Abstract] [Full Text] [Related]

  • 11. Serum macrophage colony-stimulating factor (M-CSF) levels in patients with epithelial ovarian cancer.
    Gadducci A, Ferdeghini M, Castellani C, Annicchiarico C, Prontera C, Facchini V, Bianchi R, Genazzani AR.
    Gynecol Oncol; 1998 Jul 01; 70(1):111-4. PubMed ID: 9698485
    [Abstract] [Full Text] [Related]

  • 12. Macrophage colony-stimulating factor as a tumor marker for epithelial ovarian cancer.
    Fuith LC, Czarnecki M, Wachter H, Fuchs D.
    Obstet Gynecol; 1994 May 01; 83(5 Pt 1):801. PubMed ID: 8164949
    [No Abstract] [Full Text] [Related]

  • 13. [The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients].
    Ławicki S, Czygier M, Omyła J, Bedkowska E, Szmitkowski M.
    Pol Merkur Lekarski; 2007 Oct 01; 23(136):259-63. PubMed ID: 18293847
    [Abstract] [Full Text] [Related]

  • 14. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
    Ławicki S, Szmitkowski M, Wojtukiewicz M.
    Clin Chim Acta; 2006 Sep 01; 371(1-2):112-6. PubMed ID: 16631152
    [Abstract] [Full Text] [Related]

  • 15. Detection of serum transforming growth factor-alpha in patients of primary epithelial ovarian cancers by enzyme immunoassay.
    Chien CH, Huang CC, Lin YH, Shen J, Chow SN.
    Gynecol Oncol; 1997 Sep 01; 66(3):405-10. PubMed ID: 9299253
    [Abstract] [Full Text] [Related]

  • 16. Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients.
    Hefler L, Tempfer C, Heinze G, Mayerhofer K, Breitenecker G, Leodolter S, Reinthaller A, Kainz C.
    Br J Cancer; 1999 Nov 01; 81(5):855-9. PubMed ID: 10555758
    [Abstract] [Full Text] [Related]

  • 17. Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer.
    Brakora KA, Lee H, Yusuf R, Sullivan L, Harris A, Colella T, Seiden MV.
    Gynecol Oncol; 2004 May 01; 93(2):361-5. PubMed ID: 15099946
    [Abstract] [Full Text] [Related]

  • 18. [The CA-125 tumor marker in epithelial ovarian cancers of stage I].
    Nagele F, Vavra N, Kurz C, Sevelda P.
    Wien Klin Wochenschr; 1993 May 01; 105(20):585-8. PubMed ID: 8259686
    [Abstract] [Full Text] [Related]

  • 19. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].
    Sun LX, Wu Y, Han HQ, Wang QH.
    Ai Zheng; 2003 Jan 01; 22(1):58-61. PubMed ID: 12561438
    [Abstract] [Full Text] [Related]

  • 20. Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3.
    Jacobs IJ, Oram DH, Bast RC.
    Obstet Gynecol; 1992 Sep 01; 80(3 Pt 1):396-9. PubMed ID: 1495694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.